USA: (+1) 929-659-6832 | EU: (+44) 73-0721-4177

ⓘ 8th Edition 2026 Revenue: Million Volume/Consumption: Million Units

Global mRNA Vaccine Market Analysis 2026

Name: Global mRNA Vaccine Market Analysis 2026
Brand: Cognitive Market Research
SKU: CMR411250
Rating: 4.8 (18 reviews)
Author: Supriya Yadav

Proprietary Database, Market Surveys, Strategic Consultation & Advisory Services, Industry & Competitive Intelligence — Revenue, Volume, Production, Trade Analysis, Market Size, Share, Forecast, Drivers, Trends, Growth Opportunities, ESG and more.

Market · 2021

$8749.34 Million

▸ Historical

Market · 2025

$12983.6 Million

▸ Base year

Forecast · 2033

$28591.4 Million

▲ Growth target

CAGR 2025–2033

10.371%

▲ Compound growth

Base / Forecast

2025/2034

▸ Timeline

Data Timeline	Historical Data: 2022–2025 \| Base Year: 2025 \| Forecast Period: 2026–2034
Type Segment	Conventional mRNA Vaccines, Self-amplifying mRNA Vaccines
Application Segment	Cytomegalovirus (CMV), Influenza, Rabies, Cancer, COVID-19, Others

Route of Administration Segment	IV, Subcutaneous
End-user Segment	Hospitals, Clinics, Research Centres, Others
Regions & Countries	North America (United States, Canada, Mexico) Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe) Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC) South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America) Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East) Africa (East Africa, West Africa, North Africa, South Africa)

Global mRNA Vaccine Market Analysis 2026

250+ Pages · Global · 4.8

Author By: Supriya Yadav

Industry Expert: Not Disclosed (NDA)

Data Updated: April 2026

Report ID: CMR411250 | Pages: 250+

Rating: 4.8 | Review: 18

Format: Athenaeum Dashboard, PDF, Excel, MS Word, Cloud & AI Assistant

📅 Book a consultation

Contents

Global mRNA Vaccine Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Top Countries — Revenue

Million

Loading…

Share Distribution

Loading…

Market Dynamics of Global mRNA Vaccine Market Analysis

↑ Growth Drivers

Rise in the prevalence of infectious diseases Mounting R&D Investment

↓ Restraints

High Development and Manufacturing Costs Regulatory and Safety Concerns

~ Trends

Expansion Beyond Infectious Diseases Improvements in Stability and Delivery Systems

Access the full forecast model.

Country-level data · Company profiles · Editable dataset · Analyst consultation included.

Global mRNA Vaccine Market Analysis — Presence

Interactive World Map

Click countries to explore

Loading map…

Regional and Country Analysis

North America — United States, Canada, Mexico
Europe — United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe
Asia Pacific — China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC
South America — Brazil, Argentina, Colombia, Peru, Chile, Rest of South America
Middle East — Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East
Africa — East Africa, West Africa, North Africa, South Africa

Region / Country	2021 (A)	2025 (A)	2033 (P)	CAGR

A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.

Unlock full regional dataset →

Segmentation Analysis

Market size by (Illustrative, 2025)

Share distribution (2025)

Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.

To learn more about market share and segmentation, request the free sample pages.

The pharmaceutical and healthcare industry is highly competitive, with players expanding through product launches, M&A, partnerships, and regulatory approvals. The Global mRNA Vaccine Market Analysis market report covers financials, market share, SWOTs, and responses to Tariffs, while providing global, regional, and country-level forecasts supported by value chain, patent analysis, and a competitive matrix serving as a key resource for stakeholders and investors.

Click any bar or cell to request the full company profile

Company	2022 (A)	2023 (A)	2024 (A)	2025 (A)
Moderna Inc.	•••	•••	•••	•••
BioNTech SE.	•••	•••	•••	•••
CureVac SE	•••	•••	•••	•••
Arcturus Therapeutics Inc.	•••	•••	•••	•••
Sanofi	•••	•••	•••	•••
GSK plc	•••	•••	•••	•••
Ethris	•••	•••	•••	•••
Pfizer Inc.	•••	•••	•••	•••
Others	•••	•••	•••	•••

Revenue data requires full access. *2nd & 3rd tier companies available on enquiry.

Request company profile for validation →

Report Scope & Analysis

As per Cognitive Market Research's latest published report, the Global mRNA vaccine market size was $1.45 Billion in 2022 and it is forecasted to reach $3.86 Billion by 2030. mRNA vaccine Industry's Compound Annual Growth Rate will be 12.8 % from 2023 to 2030. Whereas a Self-amplifying mRNA Vaccines Market Share was 61.25%, a leading type of mRNA Vaccine.

Introduction of mRNA Vaccine

mRNA is a biological substance that is given in a series of shots to protect the body from developing a disease. It works by triggering the immune system to create antibodies. These antibodies then fight bacteria and viruses that cause disease. Most mRNA vaccines are multi-antigen vaccines, where mRNA has advantages over peptide-based vaccines. For more than 30 years, healthcare providers are using this technology to prevent infectious and oncological diseases. They are also studying mRNA vaccines to treat diseases like multiple sclerosis.

Moreover, mRNA vaccines are used to prevent severe illness from COVID-19 infection. Thus, 2020 was a breakout year for mRNA therapeutics with the launch and widespread use of mRNA vaccines for COVID-19.

Global mRNA Vaccine Market Analysis Insights Video

Analyst Conclusion

The mRNA Vaccines market size is estimated to reach $91.14 Billion by 2029 with growing at CAGR of 6.78% from 2022-2029.
Increasing investment in Research and development is expected fuel the market in the near future.
Hospital segment held the major share of total mRNA Vaccines Market in 2022.
IV was the major contributor with 61.25% Share of total mRNA Vaccine Market in 2021.
In terms of revenue, Asia Pacific is expected to show fastest growth in the coming years.

Supriya Yadav

Research Analyst · Cognitive Market Research

Supriya is a Team Lead at Cognitive Market Research & Consulting, leading research initiatives and strategic intelligence projects across the Healthcare, Pharmaceuticals, and Medical Devices & Consumables sectors. With more than two years of experience in market research and data analysis, she plays a key role in helping organizations navigate complex healthcare ecosystems, identify emerging opportunities, and make informed business decisions through data-driven insights and market intelligence. Combining expertise in both primary and secondary research methodologies with a strong academic foundation in Marketing and Finance, Supriya oversees the execution of market assessments, competitive intelligence studies, forecasting models, stakeholder interviews, trend analysis, and custom consulting engagements. She collaborates with healthcare providers, pharmaceutical manufacturers, medical device companies, industry experts, and other key stakeholders to gather firsthand market perspectives while validating findings through extensive research. Her ability to interpret clinical, commercial, and market data enables clients to better understand industry developments, regulatory influences, innovation trends, and competitive dynamics. In her leadership role, she manages end-to-end research projects and guides cross-functional teams in delivering high-quality market reports, consulting solutions, and strategic studies. Her expertise in market estimation, forecasting, and analytical modeling helps organizations evaluate market potential, assess growth opportunities, strengthen competitive positioning, and support strategic planning initiatives. By transforming complex healthcare and life sciences data into actionable business intelligence, she enables clients to make confident decisions in rapidly evolving market environments. Driven by a passion for healthcare innovation and continuous professional development, Supriya remains committed to staying ahead of industry trends, technological advancements, and changing market conditions. Her leadership, analytical mindset, and dedication to research excellence help organizations mitigate risks, capitalize on emerging opportunities, and achieve sustainable growth across the global healthcare and life sciences landscape.

LinkedIn Profile Book Appointment

Frequently Asked Questions

What are the major factors influencing growth of mRNA Vaccines?

Rise in the prevalence of infectious diseases Mounting R&D Investment.

Which region has gained highest market share across the globe?

North America is dominating the mRNA Vaccines market followed by APAC.

What market research methods have been used to analyze complete market size?

Study involved in-depth qualitative and quantitative analyses of the market. Moreover, research study involves the use of secondary sources and databases such as key companies’ annual reports, paid & public database, Bloomberg, and Factiva to identify and collect information useful for a technical and market-oriented study of the global mRNA vaccines market. Market value evaluation is done by using top-down as well as bottom-up analysis.

Does the study include an examination of the COVID-19 impacts?

Yes, the report includes a COVID-19 impact analysis.

What is the study period of this market?

The report has been analyzed from year 2017 to 2029 in which 2017-2021: Historic Period 2022: Base Year 2023-2029: Forecast Period

★ Reviews

Rate this report

Global mRNA Vaccine Market Analysis — Table of Contents

Disclaimer: Redacted sample for representative purposes. Charts and data do not depict actual statistics. TOC varies by license selection.

Type	Conventional mRNA Vaccines, Self-amplifying mRNA Vaccines
Application	Cytomegalovirus (CMV), Influenza, Rabies, Cancer, COVID-19, Others
Route of Administration	IV, Subcutaneous
End-user	Hospitals, Clinics, Research Centres, Others
List of Competitors	Moderna Inc., BioNTech SE., CureVac SE, Arcturus Therapeutics Inc., Sanofi, GSK plc, Ethris, Pfizer Inc., Others

Additional data which we are providing for mRNA Vaccine market

Competitive Landscape

Pipeline Analysis
Technology Benchmarking
Strategic Alliances
Funding & Investment Trends

Market Dynamics Deep Dive

Patent Landscape
Regulatory Pathways
Cost Structure Analysis

Unmet Needs & Opportunity Mapping

High-Gap Disease Indications
Geographic Hotspots
Barriers & Risk Assessment

Forecast Enhancements

Scenario Analysis
Impact of Policy Changes
Sensitivity Analysis

Industry Ecosystem Mapping

Raw Material Suppliers
CDMOs / CMOs
Logistics & Cold-Chain Partners

1.1 Global Power Realignment & Strategic Alliances
1.2 Geopolitical Risk Landscape & Conflict Hotspots
1.3 International Trade Relations & Market Access Environment
1.4 Regulatory & Policy Shifts Impacting Cross-Border Operations
1.5 Supply Chain Resilience, Localization & Resource Nationalism
1.6 Technology Sovereignty & Digital Geopolitics
1.7 Strategic Implications for Investment, Growth & Market Entry

2.1 Competitive Landscape Disruption & Strategic Shifts
2.2 AI-Driven Transformation of Industry Value Chain
2.3 Evolution of Business Models & Revenue Streams
2.4 Operational Efficiency & Cost Structure Transformation
2.5 Product, Service & Innovation Acceleration
2.6 Customer Behavior & Demand Evolution
2.7 Future Outlook: AI-Led Market Evolution & Strategic Implications

3.1 Global mRNA Vaccine Revenue Market Size, Trend Analysis 2022 - 2034
3.2 Global mRNA Vaccine Volume Market Sales, Trend Analysis 2022 - 2034
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.

3.3 Global mRNA Vaccine Market Size By Regions 2022 - 2034
- 3.3.1 Global mRNA Vaccine Revenue Market Size By Region
- 3.3.2 Global mRNA Vaccine Volume Market Sales By Region
3.4 Global mRNA Vaccine Market Size By Type 2022 - 2034
- 3.4.1 Conventional mRNA Vaccines Market Size
- 3.4.2 Self-amplifying mRNA Vaccines Market Size
3.5 Global mRNA Vaccine Volume Market Sales By Type 2022 - 2034
- 3.5.1 Conventional mRNA Vaccines Sales Volume
- 3.5.2 Self-amplifying mRNA Vaccines Sales Volume
3.6 Global mRNA Vaccine Market Size By Application 2022 - 2034
- 3.6.1 Cytomegalovirus (CMV) Market Size
- 3.6.2 Influenza Market Size
- 3.6.3 Rabies Market Size
- 3.6.4 Cancer Market Size
- 3.6.5 COVID-19 Market Size
- 3.6.6 Others Market Size
3.7 Global mRNA Vaccine Volume Market Sales By Application 2022 - 2034
- 3.7.1 Cytomegalovirus (CMV) Sales Volume
- 3.7.2 Influenza Sales Volume
- 3.7.3 Rabies Sales Volume
- 3.7.4 Cancer Sales Volume
- 3.7.5 COVID-19 Sales Volume
- 3.7.6 Others Sales Volume
3.8 Global mRNA Vaccine Market Size By Route of Administration 2022 - 2034
- 3.8.1 IV Market Size
- 3.8.2 Subcutaneous Market Size
3.9 Global mRNA Vaccine Volume Market Sales By Route of Administration 2022 - 2034
- 3.9.1 IV Sales Volume
- 3.9.2 Subcutaneous Sales Volume
3.10 Global mRNA Vaccine Market Size By End-user for 2022 - 2034
- 3.10.1 Hospitals Market Size
- 3.10.2 Clinics Market Size
- 3.10.3 Research Centres Market Size
- 3.10.4 Others Market Size
3.11 Global mRNA Vaccine Volume Market Sales By End-user 2022 - 2034
- 3.11.1 Hospitals Sales Volume
- 3.11.2 Clinics Sales Volume
- 3.11.3 Research Centres Sales Volume
- 3.11.4 Others Sales Volume
3.12 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)

3.13 Executive Summary Global Market (2021 vs 2025 vs 2033)
- 3.13.1 Regional Market Revenue Summary 2021 vs 2025 vs 2033
- 3.13.2 Regional Volume Market Summary 2021 vs 2025 vs 2033
- 3.13.3 Global Market Revenue Split By Type
- 3.13.4 Global Volume Market Split By Type
- 3.13.5 Global Market Revenue Split By Application
- 3.13.6 Global Volume Market Split By Application
- 3.13.7 Global Market Revenue Split By Route of Administration
- 3.13.8 Global Volume Market Split By Route of Administration
- 3.13.9 Global Market Revenue Split By End-user
- 3.13.10 Global Volume Market Split By End-user
- Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
  
  3.13.11 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities

4.1 North America mRNA Vaccine Market Outlook
- 4.1.1 North America mRNA Vaccine Market Size 2022 - 2034
- 4.1.2 North America mRNA Vaccine Volume Market Sales 2022 - 2034
- 4.1.3 North America mRNA Vaccine Market Size By Country 2022 - 2034
- 4.1.4 North America mRNA Vaccine Volume Market Sales By Country 2022 - 2034
- 4.1.5 North America mRNA Vaccine Market Size by Type 2022 - 2034
  - 4.1.5.1 North America Conventional mRNA Vaccines Market Size
  - 4.1.5.2 North America Self-amplifying mRNA Vaccines Market Size
- 4.1.6 North America mRNA Vaccine Volume Market Sales by Type 2022 - 2034
  - 4.1.6.1 North America Conventional mRNA Vaccines Sales Volume
  - 4.1.6.2 North America Self-amplifying mRNA Vaccines Sales Volume
- 4.1.7 North America mRNA Vaccine Market Size by Application 2022 - 2034
  - 4.1.7.1 North America Cytomegalovirus (CMV) Market Size
  - 4.1.7.2 North America Influenza Market Size
  - 4.1.7.3 North America Rabies Market Size
  - 4.1.7.4 North America Cancer Market Size
  - 4.1.7.5 North America COVID-19 Market Size
  - 4.1.7.6 North America Others Market Size
- 4.1.8 North America mRNA Vaccine Volume Market Sales by Application 2022 - 2034
  - 4.1.8.1 North America Cytomegalovirus (CMV) Sales Volume
  - 4.1.8.2 North America Influenza Sales Volume
  - 4.1.8.3 North America Rabies Sales Volume
  - 4.1.8.4 North America Cancer Sales Volume
  - 4.1.8.5 North America COVID-19 Sales Volume
  - 4.1.8.6 North America Others Sales Volume
- 4.1.9 North America mRNA Vaccine Market Size by Route of Administration 2022 - 2034
  - 4.1.9.1 North America IV Market Size
  - 4.1.9.2 North America Subcutaneous Market Size
- 4.1.10 North America mRNA Vaccine Volume Market Sales by Route of Administration 2022 - 2034
  - 4.1.10.1 North America IV Sales Volume
  - 4.1.10.2 North America Subcutaneous Sales Volume
- 4.1.11 North America mRNA Vaccine Market Size by End-user 2022 - 2034
  - 4.1.11.1 North America Hospitals Market Size
  - 4.1.11.2 North America Clinics Market Size
  - 4.1.11.3 North America Research Centres Market Size
  - 4.1.11.4 North America Others Market Size
- 4.1.12 North America mRNA Vaccine Volume Market Sales by End-user 2022 - 2034
  - 4.1.12.1 North America Hospitals Sales Volume
  - 4.1.12.2 North America Clinics Sales Volume
  - 4.1.12.3 North America Research Centres Sales Volume
  - 4.1.12.4 North America Others Sales Volume

5.1 Europe mRNA Vaccine Market Outlook
- 5.1.1 Europe mRNA Vaccine Market Size 2022 - 2034
- 5.1.2 Europe mRNA Vaccine Volume Market Sales 2022 - 2034
- 5.1.3 Europe mRNA Vaccine Market Size By Country 2022 - 2034
- 5.1.4 Europe mRNA Vaccine Volume Market Sales By Country 2022 - 2034
- 5.1.5 Europe mRNA Vaccine Market Size by Type 2022 - 2034
  - 5.1.5.1 Europe Conventional mRNA Vaccines Market Size
  - 5.1.5.2 Europe Self-amplifying mRNA Vaccines Market Size
- 5.1.6 Europe mRNA Vaccine Volume Market Sales by Type 2022 - 2034
  - 5.1.6.1 Europe Conventional mRNA Vaccines Sales Volume
  - 5.1.6.2 Europe Self-amplifying mRNA Vaccines Sales Volume
- 5.1.7 Europe mRNA Vaccine Market Size by Application 2022 - 2034
  - 5.1.7.1 Europe Cytomegalovirus (CMV) Market Size
  - 5.1.7.2 Europe Influenza Market Size
  - 5.1.7.3 Europe Rabies Market Size
  - 5.1.7.4 Europe Cancer Market Size
  - 5.1.7.5 Europe COVID-19 Market Size
  - 5.1.7.6 Europe Others Market Size
- 5.1.8 Europe mRNA Vaccine Volume Market Sales by Application 2022 - 2034
  - 5.1.8.1 Europe Cytomegalovirus (CMV) Sales Volume
  - 5.1.8.2 Europe Influenza Sales Volume
  - 5.1.8.3 Europe Rabies Sales Volume
  - 5.1.8.4 Europe Cancer Sales Volume
  - 5.1.8.5 Europe COVID-19 Sales Volume
  - 5.1.8.6 Europe Others Sales Volume
- 5.1.9 Europe mRNA Vaccine Market Size by Route of Administration 2022 - 2034
  - 5.1.9.1 Europe IV Market Size
  - 5.1.9.2 Europe Subcutaneous Market Size
- 5.1.10 Europe mRNA Vaccine Volume Market Sales by Route of Administration 2022 - 2034
  - 5.1.10.1 Europe IV Sales Volume
  - 5.1.10.2 Europe Subcutaneous Sales Volume
- 5.1.11 Europe mRNA Vaccine Market Size by End-user 2022 - 2034
  - 5.1.11.1 Europe Hospitals Market Size
  - 5.1.11.2 Europe Clinics Market Size
  - 5.1.11.3 Europe Research Centres Market Size
  - 5.1.11.4 Europe Others Market Size
- 5.1.12 Europe mRNA Vaccine Volume Market Sales by End-user 2022 - 2034
  - 5.1.12.1 Europe Hospitals Sales Volume
  - 5.1.12.2 Europe Clinics Sales Volume
  - 5.1.12.3 Europe Research Centres Sales Volume
  - 5.1.12.4 Europe Others Sales Volume

6.1 Asia Pacific mRNA Vaccine Market Outlook
- 6.1.1 Asia Pacific mRNA Vaccine Market Size 2022 - 2034
- 6.1.2 Asia Pacific mRNA Vaccine Volume Market Sales 2022 - 2034
- 6.1.3 Asia Pacific mRNA Vaccine Market Size By Country 2022 - 2034
- 6.1.4 Asia Pacific mRNA Vaccine Volume Market Sales By Country 2022 - 2034
- 6.1.5 Asia Pacific mRNA Vaccine Market Size by Type 2022 - 2034
  - 6.1.5.1 Asia Pacific Conventional mRNA Vaccines Market Size
  - 6.1.5.2 Asia Pacific Self-amplifying mRNA Vaccines Market Size
- 6.1.6 Asia Pacific mRNA Vaccine Volume Market Sales by Type 2022 - 2034
  - 6.1.6.1 Asia Pacific Conventional mRNA Vaccines Sales Volume
  - 6.1.6.2 Asia Pacific Self-amplifying mRNA Vaccines Sales Volume
- 6.1.7 Asia Pacific mRNA Vaccine Market Size by Application 2022 - 2034
  - 6.1.7.1 Asia Pacific Cytomegalovirus (CMV) Market Size
  - 6.1.7.2 Asia Pacific Influenza Market Size
  - 6.1.7.3 Asia Pacific Rabies Market Size
  - 6.1.7.4 Asia Pacific Cancer Market Size
  - 6.1.7.5 Asia Pacific COVID-19 Market Size
  - 6.1.7.6 Asia Pacific Others Market Size
- 6.1.8 Asia Pacific mRNA Vaccine Volume Market Sales by Application 2022 - 2034
  - 6.1.8.1 Asia Pacific Cytomegalovirus (CMV) Sales Volume
  - 6.1.8.2 Asia Pacific Influenza Sales Volume
  - 6.1.8.3 Asia Pacific Rabies Sales Volume
  - 6.1.8.4 Asia Pacific Cancer Sales Volume
  - 6.1.8.5 Asia Pacific COVID-19 Sales Volume
  - 6.1.8.6 Asia Pacific Others Sales Volume
- 6.1.9 Asia Pacific mRNA Vaccine Market Size by Route of Administration 2022 - 2034
  - 6.1.9.1 Asia Pacific IV Market Size
  - 6.1.9.2 Asia Pacific Subcutaneous Market Size
- 6.1.10 Asia Pacific mRNA Vaccine Volume Market Sales by Route of Administration 2022 - 2034
  - 6.1.10.1 Asia Pacific IV Sales Volume
  - 6.1.10.2 Asia Pacific Subcutaneous Sales Volume
- 6.1.11 Asia Pacific mRNA Vaccine Market Size by End-user 2022 - 2034
  - 6.1.11.1 Asia Pacific Hospitals Market Size
  - 6.1.11.2 Asia Pacific Clinics Market Size
  - 6.1.11.3 Asia Pacific Research Centres Market Size
  - 6.1.11.4 Asia Pacific Others Market Size
- 6.1.12 Asia Pacific mRNA Vaccine Volume Market Sales by End-user 2022 - 2034
  - 6.1.12.1 Asia Pacific Hospitals Sales Volume
  - 6.1.12.2 Asia Pacific Clinics Sales Volume
  - 6.1.12.3 Asia Pacific Research Centres Sales Volume
  - 6.1.12.4 Asia Pacific Others Sales Volume

7.1 South America mRNA Vaccine Market Outlook
- 7.1.1 South America mRNA Vaccine Market Size 2022 - 2034
- 7.1.2 South America mRNA Vaccine Volume Market Sales 2022 - 2034
- 7.1.3 South America mRNA Vaccine Market Size By Country 2022 - 2034
- 7.1.4 South America mRNA Vaccine Volume Market Sales By Country 2022 - 2034
- 7.1.5 South America mRNA Vaccine Market Size by Type 2022 - 2034
  - 7.1.5.1 South America Conventional mRNA Vaccines Market Size
  - 7.1.5.2 South America Self-amplifying mRNA Vaccines Market Size
- 7.1.6 South America mRNA Vaccine Volume Market Sales by Type 2022 - 2034
  - 7.1.6.1 South America Conventional mRNA Vaccines Sales Volume
  - 7.1.6.2 South America Self-amplifying mRNA Vaccines Sales Volume
- 7.1.7 South America mRNA Vaccine Market Size by Application 2022 - 2034
  - 7.1.7.1 South America Cytomegalovirus (CMV) Market Size
  - 7.1.7.2 South America Influenza Market Size
  - 7.1.7.3 South America Rabies Market Size
  - 7.1.7.4 South America Cancer Market Size
  - 7.1.7.5 South America COVID-19 Market Size
  - 7.1.7.6 South America Others Market Size
- 7.1.8 South America mRNA Vaccine Volume Market Sales by Application 2022 - 2034
  - 7.1.8.1 South America Cytomegalovirus (CMV) Sales Volume
  - 7.1.8.2 South America Influenza Sales Volume
  - 7.1.8.3 South America Rabies Sales Volume
  - 7.1.8.4 South America Cancer Sales Volume
  - 7.1.8.5 South America COVID-19 Sales Volume
  - 7.1.8.6 South America Others Sales Volume
- 7.1.9 South America mRNA Vaccine Market Size by Route of Administration 2022 - 2034
  - 7.1.9.1 South America IV Market Size
  - 7.1.9.2 South America Subcutaneous Market Size
- 7.1.10 South America mRNA Vaccine Volume Market Sales by Route of Administration 2022 - 2034
  - 7.1.10.1 South America IV Sales Volume
  - 7.1.10.2 South America Subcutaneous Sales Volume
- 7.1.11 South America mRNA Vaccine Market Size by End-user 2022 - 2034
  - 7.1.11.1 South America Hospitals Market Size
  - 7.1.11.2 South America Clinics Market Size
  - 7.1.11.3 South America Research Centres Market Size
  - 7.1.11.4 South America Others Market Size
- 7.1.12 South America mRNA Vaccine Volume Market Sales by End-user 2022 - 2034
  - 7.1.12.1 South America Hospitals Sales Volume
  - 7.1.12.2 South America Clinics Sales Volume
  - 7.1.12.3 South America Research Centres Sales Volume
  - 7.1.12.4 South America Others Sales Volume

8.1 Middle East mRNA Vaccine Market Outlook
- 8.1.1 Middle East mRNA Vaccine Market Size 2022 - 2034
- 8.1.2 Middle East mRNA Vaccine Volume Market Sales 2022 - 2034
- 8.1.3 Middle East mRNA Vaccine Market Size By Country 2022 - 2034
- 8.1.4 Middle East mRNA Vaccine Volume Market Sales By Country 2022 - 2034
- 8.1.5 Middle East mRNA Vaccine Market Size by Type 2022 - 2034
  - 8.1.5.1 Middle East Conventional mRNA Vaccines Market Size
  - 8.1.5.2 Middle East Self-amplifying mRNA Vaccines Market Size
- 8.1.6 Middle East mRNA Vaccine Volume Market Sales by Type 2022 - 2034
  - 8.1.6.1 Middle East Conventional mRNA Vaccines Sales Volume
  - 8.1.6.2 Middle East Self-amplifying mRNA Vaccines Sales Volume
- 8.1.7 Middle East mRNA Vaccine Market Size by Application 2022 - 2034
  - 8.1.7.1 Middle East Cytomegalovirus (CMV) Market Size
  - 8.1.7.2 Middle East Influenza Market Size
  - 8.1.7.3 Middle East Rabies Market Size
  - 8.1.7.4 Middle East Cancer Market Size
  - 8.1.7.5 Middle East COVID-19 Market Size
  - 8.1.7.6 Middle East Others Market Size
- 8.1.8 Middle East mRNA Vaccine Volume Market Sales by Application 2022 - 2034
  - 8.1.8.1 Middle East Cytomegalovirus (CMV) Sales Volume
  - 8.1.8.2 Middle East Influenza Sales Volume
  - 8.1.8.3 Middle East Rabies Sales Volume
  - 8.1.8.4 Middle East Cancer Sales Volume
  - 8.1.8.5 Middle East COVID-19 Sales Volume
  - 8.1.8.6 Middle East Others Sales Volume
- 8.1.9 Middle East mRNA Vaccine Market Size by Route of Administration 2022 - 2034
  - 8.1.9.1 Middle East IV Market Size
  - 8.1.9.2 Middle East Subcutaneous Market Size
- 8.1.10 Middle East mRNA Vaccine Volume Market Sales by Route of Administration 2022 - 2034
  - 8.1.10.1 Middle East IV Sales Volume
  - 8.1.10.2 Middle East Subcutaneous Sales Volume
- 8.1.11 Middle East mRNA Vaccine Market Size by End-user 2022 - 2034
  - 8.1.11.1 Middle East Hospitals Market Size
  - 8.1.11.2 Middle East Clinics Market Size
  - 8.1.11.3 Middle East Research Centres Market Size
  - 8.1.11.4 Middle East Others Market Size
- 8.1.12 Middle East mRNA Vaccine Volume Market Sales by End-user 2022 - 2034
  - 8.1.12.1 Middle East Hospitals Sales Volume
  - 8.1.12.2 Middle East Clinics Sales Volume
  - 8.1.12.3 Middle East Research Centres Sales Volume
  - 8.1.12.4 Middle East Others Sales Volume

9.1 Africa mRNA Vaccine Market Outlook
- 9.1.1 Africa mRNA Vaccine Market Size 2022 - 2034
- 9.1.2 Africa mRNA Vaccine Volume Market Sales 2022 - 2034
- 9.1.3 Africa mRNA Vaccine Market Size By Country 2022 - 2034
- 9.1.4 Africa mRNA Vaccine Volume Market Sales By Country 2022 - 2034
- 9.1.5 Africa mRNA Vaccine Market Size by Type 2022 - 2034
  - 9.1.5.1 Africa Conventional mRNA Vaccines Market Size
  - 9.1.5.2 Africa Self-amplifying mRNA Vaccines Market Size
- 9.1.6 Africa mRNA Vaccine Volume Market Sales by Type 2022 - 2034
  - 9.1.6.1 Africa Conventional mRNA Vaccines Sales Volume
  - 9.1.6.2 Africa Self-amplifying mRNA Vaccines Sales Volume
- 9.1.7 Africa mRNA Vaccine Market Size by Application 2022 - 2034
  - 9.1.7.1 Africa Cytomegalovirus (CMV) Market Size
  - 9.1.7.2 Africa Influenza Market Size
  - 9.1.7.3 Africa Rabies Market Size
  - 9.1.7.4 Africa Cancer Market Size
  - 9.1.7.5 Africa COVID-19 Market Size
  - 9.1.7.6 Africa Others Market Size
- 9.1.8 Africa mRNA Vaccine Volume Market Sales by Application 2022 - 2034
  - 9.1.8.1 Africa Cytomegalovirus (CMV) Sales Volume
  - 9.1.8.2 Africa Influenza Sales Volume
  - 9.1.8.3 Africa Rabies Sales Volume
  - 9.1.8.4 Africa Cancer Sales Volume
  - 9.1.8.5 Africa COVID-19 Sales Volume
  - 9.1.8.6 Africa Others Sales Volume
- 9.1.9 Africa mRNA Vaccine Market Size by Route of Administration 2022 - 2034
  - 9.1.9.1 Africa IV Market Size
  - 9.1.9.2 Africa Subcutaneous Market Size
- 9.1.10 Africa mRNA Vaccine Volume Market Sales by Route of Administration 2022 - 2034
  - 9.1.10.1 Africa IV Sales Volume
  - 9.1.10.2 Africa Subcutaneous Sales Volume
- 9.1.11 Africa mRNA Vaccine Market Size by End-user 2022 - 2034
  - 9.1.11.1 Africa Hospitals Market Size
  - 9.1.11.2 Africa Clinics Market Size
  - 9.1.11.3 Africa Research Centres Market Size
  - 9.1.11.4 Africa Others Market Size
- 9.1.12 Africa mRNA Vaccine Volume Market Sales by End-user 2022 - 2034
  - 9.1.12.1 Africa Hospitals Sales Volume
  - 9.1.12.2 Africa Clinics Sales Volume
  - 9.1.12.3 Africa Research Centres Sales Volume
  - 9.1.12.4 Africa Others Sales Volume

10.1 Top Competitors Analysis
- (Subject to Data Availability (Private Players))
  
  10.1.1 Global mRNA Vaccine Market Revenue and Share by Key Players
- 10.1.2 Global mRNA Vaccine Market Volume and Share by Key Players
- 10.1.3 Top Players Ranking 2024
- 10.1.4 New Product Launch Analysis
- 10.1.5 Industry Mergers and Acquisition Analysis
10.2 Company Profile (Data Subject to Availability) Sample Format
- Data Subject to Availability as we consider Top competitors and their market share will be delivered.
  
  10.2.1 Moderna Inc.
  - 10.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
  - 10.2.1.2 Business Overview
  - 10.2.1.3 Financials (Subject to data availability)
  - 10.2.1.4 R&D Investment (Subject to data availability)
  - 10.2.1.5 Product Types Specification
  - 10.2.1.6 Business Strategy
  - 10.2.1.7 Recent Developments
  - 10.2.1.8 Management Change
  - 10.2.1.9 S.W.O.T Analysis
- Data Subject to Availability as we consider Top competitors and their market share will be delivered.
  
  10.2.2 BioNTech SE.
  - 10.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
  - 10.2.2.2 Business Overview
  - 10.2.2.3 Financials (Subject to data availability)
  - 10.2.2.4 R&D Investment (Subject to data availability)
  - 10.2.2.5 Product Types Specification
  - 10.2.2.6 Business Strategy
  - 10.2.2.7 Recent Developments
  - 10.2.2.8 Management Change
  - 10.2.2.9 S.W.O.T Analysis
- Data Subject to Availability as we consider Top competitors and their market share will be delivered.
  
  10.2.3 CureVac SE
  - 10.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
  - 10.2.3.2 Business Overview
  - 10.2.3.3 Financials (Subject to data availability)
  - 10.2.3.4 R&D Investment (Subject to data availability)
  - 10.2.3.5 Product Types Specification
  - 10.2.3.6 Business Strategy
  - 10.2.3.7 Recent Developments
  - 10.2.3.8 Management Change
  - 10.2.3.9 S.W.O.T Analysis
- Data Subject to Availability as we consider Top competitors and their market share will be delivered.
  
  10.2.4 Arcturus Therapeutics Inc.
  - 10.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
  - 10.2.4.2 Business Overview
  - 10.2.4.3 Financials (Subject to data availability)
  - 10.2.4.4 R&D Investment (Subject to data availability)
  - 10.2.4.5 Product Types Specification
  - 10.2.4.6 Business Strategy
  - 10.2.4.7 Recent Developments
  - 10.2.4.8 Management Change
  - 10.2.4.9 S.W.O.T Analysis
- Data Subject to Availability as we consider Top competitors and their market share will be delivered.
  
  10.2.5 Sanofi
  - 10.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
  - 10.2.5.2 Business Overview
  - 10.2.5.3 Financials (Subject to data availability)
  - 10.2.5.4 R&D Investment (Subject to data availability)
  - 10.2.5.5 Product Types Specification
  - 10.2.5.6 Business Strategy
  - 10.2.5.7 Recent Developments
  - 10.2.5.8 Management Change
  - 10.2.5.9 S.W.O.T Analysis
- Data Subject to Availability as we consider Top competitors and their market share will be delivered.
  
  10.2.6 GSK plc
  - 10.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
  - 10.2.6.2 Business Overview
  - 10.2.6.3 Financials (Subject to data availability)
  - 10.2.6.4 R&D Investment (Subject to data availability)
  - 10.2.6.5 Product Types Specification
  - 10.2.6.6 Business Strategy
  - 10.2.6.7 Recent Developments
  - 10.2.6.8 Management Change
  - 10.2.6.9 S.W.O.T Analysis
- Data Subject to Availability as we consider Top competitors and their market share will be delivered.
  
  10.2.7 Ethris
  - 10.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
  - 10.2.7.2 Business Overview
  - 10.2.7.3 Financials (Subject to data availability)
  - 10.2.7.4 R&D Investment (Subject to data availability)
  - 10.2.7.5 Product Types Specification
  - 10.2.7.6 Business Strategy
  - 10.2.7.7 Recent Developments
  - 10.2.7.8 Management Change
  - 10.2.7.9 S.W.O.T Analysis
- Data Subject to Availability as we consider Top competitors and their market share will be delivered.
  
  10.2.8 Pfizer Inc.
  - 10.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
  - 10.2.8.2 Business Overview
  - 10.2.8.3 Financials (Subject to data availability)
  - 10.2.8.4 R&D Investment (Subject to data availability)
  - 10.2.8.5 Product Types Specification
  - 10.2.8.6 Business Strategy
  - 10.2.8.7 Recent Developments
  - 10.2.8.8 Management Change
  - 10.2.8.9 S.W.O.T Analysis
- Data Subject to Availability as we consider Top competitors and their market share will be delivered.
  
  10.2.9 Others
  - 10.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
  - 10.2.9.2 Business Overview
  - 10.2.9.3 Financials (Subject to data availability)
  - 10.2.9.4 R&D Investment (Subject to data availability)
  - 10.2.9.5 Product Types Specification
  - 10.2.9.6 Business Strategy
  - 10.2.9.7 Recent Developments
  - 10.2.9.8 Management Change
  - 10.2.9.9 S.W.O.T Analysis

11.1 Market Drivers
11.2 Market Restraints
11.3 Market Trends
11.4 Market Opportunity
11.5 Technological Road Map (Subject to Data Availability)
11.6 Product Life Cycle (Subject to Data Availability)
11.7 Customer and Buyer Behavior Analysis
- 11.7.1 Consumer Demographics and Target Audience Assessment
- 11.7.2 Consumer Purchase Behavior and Demand Assessment
- 11.7.3 Consumer Pricing Dynamics and Affordability Assessment
- 11.7.4 Digital Consumer Engagement and Online Adoption Analysis
- 11.7.5 Future Consumption Trends and Demand Evolution Analysis
- 11.7.6 Enterprise Procurement & Purchasing Behavior Analysis
- 11.7.7 Buyer Decision-Making & Purchase Influence Assessment
- 11.7.8 Customer Expectations & Service Experience Evaluation
- 11.7.9 Vendor Selection & Supplier Preference Analysis
- 11.7.10 Customer Retention & Loyalty Strategy Assessment
- 11.7.11 Pricing Sensitivity & Value Perception Analysis
- 11.7.12 Customer Segmentation & Demand Pattern Analysis
- 11.7.13 Relationship Management & Strategic Partnership Trends
11.8 Market Attractiveness Analysis
11.9 PESTEL Analysis
- 11.9.1 Political Factors
- 11.9.2 Economic Factors
- 11.9.3 Social Factors
- 11.9.4 Technological Factors
- 11.9.5 Legal Factors
- 11.9.6 Environmental Factors
11.10 Industrial Chain Analysis (Subject to Data Availability)
- 11.10.1 Industry Chain Analysis
- 11.10.2 Manufacturing Cost Analysis
- 11.10.3 Supply Side Analysis
  - 11.10.3.1 Raw Material Analysis
  - 11.10.3.2 Raw Material Procurement Analysis
  - 11.10.3.3 Raw Material Price Trend Analysis
11.11 Porter’s Five Forces Analysis
- 11.11.1 Bargaining Power of Suppliers
- 11.11.2 Bargaining Power of Buyers
- 11.11.3 Threat of New Entrants
- 11.11.4 Threat of Substitutes
- 11.11.5 Degree of Competition
11.12 Patent Analysis (Subject to Data Availability)
11.13 ESG Analysis

12.1 Conventional mRNA Vaccines
- 12.1.1 Global mRNA Vaccine Revenue Market Size and Share by Conventional mRNA Vaccines 2022 - 2034
- 12.1.2 Global mRNA Vaccine Volume Market Sales by Conventional mRNA Vaccines 2022 - 2034
12.2 Self-amplifying mRNA Vaccines
- 12.2.1 Global mRNA Vaccine Revenue Market Size and Share by Self-amplifying mRNA Vaccines 2022 - 2034
- 12.2.2 Global mRNA Vaccine Volume Market Sales by Self-amplifying mRNA Vaccines 2022 - 2034

13.1 Cytomegalovirus (CMV)
- 13.1.1 Global mRNA Vaccine Revenue Market Size and Share by Cytomegalovirus (CMV) 2022 - 2034
- 13.1.2 Global mRNA Vaccine Volume Market Sales by Cytomegalovirus (CMV) 2022 - 2034
13.2 Influenza
- 13.2.1 Global mRNA Vaccine Revenue Market Size and Share by Influenza 2022 - 2034
- 13.2.2 Global mRNA Vaccine Volume Market Sales by Influenza 2022 - 2034
13.3 Rabies
- 13.3.1 Global mRNA Vaccine Revenue Market Size and Share by Rabies 2022 - 2034
- 13.3.2 Global mRNA Vaccine Volume Market Sales by Rabies 2022 - 2034
13.4 Cancer
- 13.4.1 Global mRNA Vaccine Revenue Market Size and Share by Cancer 2022 - 2034
- 13.4.2 Global mRNA Vaccine Volume Market Sales by Cancer 2022 - 2034
13.5 COVID-19
- 13.5.1 Global mRNA Vaccine Revenue Market Size and Share by COVID-19 2022 - 2034
- 13.5.2 Global mRNA Vaccine Volume Market Sales by COVID-19 2022 - 2034
13.6 Others
- 13.6.1 Global mRNA Vaccine Revenue Market Size and Share by Others 2022 - 2034
- 13.6.2 Global mRNA Vaccine Volume Market Sales by Others 2022 - 2034

14.1 IV
- 14.1.1 Global mRNA Vaccine Revenue Market Size and Share by IV 2022 - 2034
- 14.1.2 Global mRNA Vaccine Volume Market Sales by IV 2022 - 2034
14.2 Subcutaneous
- 14.2.1 Global mRNA Vaccine Revenue Market Size and Share by Subcutaneous 2022 - 2034
- 14.2.2 Global mRNA Vaccine Volume Market Sales by Subcutaneous 2022 - 2034

15.1 Hospitals
- 15.1.1 Global mRNA Vaccine Revenue Market Size and Share by Hospitals 2022 - 2034
- 15.1.2 Global mRNA Vaccine Volume Market Sales by Hospitals 2022 - 2034
15.2 Clinics
- 15.2.1 Global mRNA Vaccine Revenue Market Size and Share by Clinics 2022 - 2034
- 15.2.2 Global mRNA Vaccine Volume Market Sales by Clinics 2022 - 2034
15.3 Research Centres
- 15.3.1 Global mRNA Vaccine Revenue Market Size and Share by Research Centres 2022 - 2034
- 15.3.2 Global mRNA Vaccine Volume Market Sales by Research Centres 2022 - 2034
15.4 Others
- 15.4.1 Global mRNA Vaccine Revenue Market Size and Share by Others 2022 - 2034
- 15.4.2 Global mRNA Vaccine Volume Market Sales by Others 2022 - 2034

16.1 Company Gap Assessment Analysis
16.2 Product & Service Portfolio Gap Analysis
16.3 Demand-Supply Imbalance Analysis
16.4 Market Opportunity & Unmet Needs Analysis
16.5 Technology Adoption & Digital Transformation Gap Analysis
16.6 Operational Efficiency & Process Gap Analysis
16.7 Infrastructure & Capacity Gap Analysis
16.8 Geographic Coverage & Distribution Gap Analysis
16.9 Investment Opportunity & Funding Gap Analysis
16.10 Pricing Structure & Margin Gap Analysis
16.11 Innovation & R&D Capability Gap Analysis
16.12 Policy, Compliance & Regulatory Gap Analysis
16.13 Customer Experience & Expectation Gap Analysis
16.14 Future Growth Opportunity Gap Analysis
16.15 Market Accessibility & Penetration Gap Analysis

17.1 Strategic Commercialization & Pricing Assessment

18.1 Gross Margin Overview and Industry Profitability Trends
18.2 Regional Gross Margin Performance Analysis
18.3 Supply Chain and Distribution Impact on Gross Margins
18.4 Pricing Strategy and Value-Added Margin Assessment
18.5 Key Factors Influencing Gross Margin Variability
18.6 Future Gross Margin Outlook and Profitability Trends

19.1 Key Takeaways
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.

19.2 Analyst Point of View
19.3 Assumptions and Acronyms

20.1 Primary Data Collection
- 20.1.1 Steps for Primary Data Collection
  - 20.1.1.1 Identification of KOL
- 20.1.2 Backward Integration
- 20.1.3 Forward Integration
- 20.1.4 How Primary Research Help Us
- 20.1.5 Modes of Primary Research
20.2 Secondary Research
- 20.2.1 How Secondary Research Help Us
- 20.2.2 Sources of Secondary Research
20.3 Data Validation
- 20.3.1 Data Triangulation
- 20.3.2 Top Down & Bottom Up Approach
- 20.3.3 Cross check KOL Responses with Secondary Data
20.4 Data Representation

Athenaeum AI Dashboard

Research Framework · 70:30 Primary:Secondary

Our Proprietary Methodology

Cognitive Market Research employs "The Full Truth™" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Global mRNA Vaccine Market Analysis Market analysis.

Primary Intelligence Gathering

Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.

Secondary Data Triangulation

Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.

Expert Validation Protocol

Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.

Athenaeum AI Processing

Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.

Editorial & QA Review

Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.

Data Assurance Metrics

Data Points Validated 10,400+

Expert Interviews 54

Countries Covered 39+

Company Profiles 9+

Forecast Accuracy (Historical) 94.2%

Report Pages 250+

Analytical Coverage

Market Sizing Revenue Forecast CAGR Analysis Competitor Benchmarking SWOT Porter's Analysis PESTEL Value Chain ESG Analysis Tariff Impact Patent Mapping Tech Trends

To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.

Latest News about mRNA Vaccine Market

Published At: 26-April-2024

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

In a federal lawsuit filed in Delaware, GLAXOSMITHKLINE has accused Pfizer and BioNTech of violating GSK patents pertaining to messenger RNA (mRNA) technology, which is used in the Covid-19 vaccine. GSK alleges that its patent rights in mRNA-vaccine inventions created more than ten years prior to the pandemic are violated by Pfizer and BioNTech's Comirnaty vaccines. Pfizer intends to vigorously defend against GSK's claims and is confident in its intellectual property position regarding Comirnaty. GSK is prepared to licence these patents on commercially reasonable terms to guarantee continuous patient access because it thinks that its patents established the fundamental technology used in Pfizer and BioNTech's Covid-19 mRNA vaccines. The lawsuit is an addition to a string of high-profile US court disputes concerning patent payments for Moderna, BioNTech, and Pfizer vaccines. Spikevax brought in $6.7 billion for Moderna last year, while Pfizer generated $11.2 billion from Comirnaty sales.

Source Link: https://www.reuters.com/business/healthcare-pharmaceuticals/glaxosmithkline-sues-pfizer-biontech-over-covid-19-vaccine-technology-2024-04-25/

Published At: 20-April-2024

China's drugmakers can't sell mRNA shots but haven't quit yet

China is facing challenges in developing vaccines due to idle production sites and a lack of emergency clearances for mRNA COVID injections, which has affected Walvax Biotechnology, CSPC Pharmaceutical Group, and Stemirna Therapeutics. The Chinese firms are not currently producing three of their vaccines intended for the Chinese market, but they have been working on creating mRNA vaccines that have received some approval in Asia. Due to a lack of demand, Stemirna Therapeutics has stopped construction at a proposed vaccination plant in Shanghai. Moderna is establishing manufacturing in Shanghai with the intention of launching up to 15 new mRNA medications in the next five years and advancing up to 50 candidates into clinical trials. Moderna created one of the first mRNA vaccines against COVID in history.

Source Link: https://www.reuters.com/business/healthcare-pharmaceuticals/chinas-drugmakers-cant-sell-mrna-shots-havent-quit-yet-2024-04-19/

Latest Articles about mRNA Vaccine Market

By Surabhi Bhaiyya Published At: 07-July-2026 Updated At: 27-July-2023

A Global Transformation in Healthcare the Force of mRNA Vaccines

mRNA vaccine technology keeps developing, we can expect considerably more breakthroughs and advancements that will shape the future of immunization and contribute to a healthier, safer world for all.

Sources from Pharma & Healthcare Industry

How We Serve You

Three Pillars of Market Intelligence

We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Global mRNA Vaccine Market Analysis market.

Service 01

Market Survey

B2B B2C

Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the global mrna vaccine market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.

What's Included

Buyer intent & sentiment analysis
Purchase cycle mapping
Price sensitivity research
Channel preference profiling
Competitive perception study

Most Requested

Service 02

Customized Market Data & Reports

Custom Ready Report

Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.

What's Included

Ready syndicate report (250+ pages)
Custom data scope & segmentation
Excel quantitative models
Board-ready PPT with key findings
Secure cloud portal access

Service 03

Strategic Consultation

With Survey With Report

Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.

What's Included